ExCeL London and the London Convention Bureau have announced that London has been selected as the host city for the 2021 European AIDS Conference (EACS).
Organised by the European AIDS Clinical Society, the 18th edition of the event will be held at ExCeL London, 27-30 October.
EACS is the latest medical association to have chosen London and ExCeL for events between 2021 and 2025. Others include the European Society of Cardiology (ESC), International Society of Magnetic Resonance in Medicine (ISMRM) and the International Society on Thrombosis and Haemostasis (ISTH).
Next year will also see the return of key events, including EASL (European Association for the Study of the Liver), EWMA (European Wound Management Association) and EAACI (European Academy of Allergy and Clinical Immunology).
Dr Sanjay Bhagani, President-elect of the European AIDS Clinical Society and Consultant Physician, Royal Free Hospital, London, said: “We are delighted to be hosting the 18th European HIV Conference in London in 2021. The UK has made great progress in achieving and surpassing the UNAIDS targets for the Fast-track strategy for eliminating AIDS as a major Global Health threat by 2030. This will be a unique opportunity to share our experience and advances in science with partners and colleagues across Europe and globally and learn from each other. London will provide a truly multi-cultural experience for all our delegates.”
Suzanne Singleton, Head of Associations at London Convention Bureau says that, “with four of the world’s top 20 universities for life sciences in London, Cambridge and Oxford, and over 350 medtech companies based in London, event planners can benefit from access to leading medical professionals, thought leaders and sponsors”.
Events hosted at ExCeL London generate £4.5bn (US$5.79bn) in economic impact for London and support 37,600 jobs. Under the ownership of ADNEC, ExCeL London has seen significant investment in new facilities, including the opening of London’s International Convention Centre (ICC) and onsite hotel developments.